OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Change patient management
Safety
Observational
Highlighted
Clinical outcomes
3 Publications
found
Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.
b
Circulation. Cardiovascular interventions
June 1, 2018
p
ACT Guided Heparinization
c
Change patient management
Clinical outcomes
Highlighted
Observational
Safety
Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
b
The Annals of pharmacotherapy
March 1, 2015
p
ACT Guided Heparinization
c
Change patient management
Clinical outcomes
Highlighted
Observational
Safety
Impact of international normalized ratio and activated clotting time on unfractionated heparin dosing during ablation of atrial fibrillation.
b
Circulation. Arrhythmia and electrophysiology
June 1, 2013
p
ACT Guided Heparinization
c
Change patient management
Clinical outcomes
Highlighted
Observational
Safety
